nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Oral pain—Sorafenib—liver cancer	0.162	0.162	CcSEcCtD
Phentolamine—Oral pain—Epirubicin—liver cancer	0.0598	0.0599	CcSEcCtD
Phentolamine—Oral pain—Doxorubicin—liver cancer	0.0553	0.0554	CcSEcCtD
Phentolamine—Blood pressure increased—Sorafenib—liver cancer	0.0422	0.0423	CcSEcCtD
Phentolamine—Abdominal pain upper—Sorafenib—liver cancer	0.028	0.028	CcSEcCtD
Phentolamine—Acute coronary syndrome—Sorafenib—liver cancer	0.0233	0.0233	CcSEcCtD
Phentolamine—Myocardial infarction—Sorafenib—liver cancer	0.0231	0.0232	CcSEcCtD
Phentolamine—Cardiac disorder—Sorafenib—liver cancer	0.0197	0.0197	CcSEcCtD
Phentolamine—Flushing—Sorafenib—liver cancer	0.0197	0.0197	CcSEcCtD
Phentolamine—Angiopathy—Sorafenib—liver cancer	0.0192	0.0193	CcSEcCtD
Phentolamine—Injection site pain—Epirubicin—liver cancer	0.0191	0.0192	CcSEcCtD
Phentolamine—Mediastinal disorder—Sorafenib—liver cancer	0.0191	0.0191	CcSEcCtD
Phentolamine—Arrhythmia—Sorafenib—liver cancer	0.0189	0.019	CcSEcCtD
Phentolamine—Injection site pain—Doxorubicin—liver cancer	0.0177	0.0177	CcSEcCtD
Phentolamine—Hypertension—Sorafenib—liver cancer	0.0159	0.016	CcSEcCtD
Phentolamine—Injection site reaction—Epirubicin—liver cancer	0.0155	0.0155	CcSEcCtD
Phentolamine—Nervous system disorder—Sorafenib—liver cancer	0.0148	0.0148	CcSEcCtD
Phentolamine—Injection site reaction—Doxorubicin—liver cancer	0.0143	0.0144	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Sorafenib—liver cancer	0.013	0.013	CcSEcCtD
Phentolamine—Pain—Sorafenib—liver cancer	0.0129	0.0129	CcSEcCtD
Phentolamine—Gastrointestinal pain—Sorafenib—liver cancer	0.0123	0.0123	CcSEcCtD
Phentolamine—Abdominal pain—Sorafenib—liver cancer	0.0119	0.0119	CcSEcCtD
Phentolamine—Asthenia—Sorafenib—liver cancer	0.0108	0.0108	CcSEcCtD
Phentolamine—Pruritus—Sorafenib—liver cancer	0.0107	0.0107	CcSEcCtD
Phentolamine—Orthostatic hypotension—Epirubicin—liver cancer	0.0103	0.0104	CcSEcCtD
Phentolamine—Abdominal pain upper—Epirubicin—liver cancer	0.0103	0.0104	CcSEcCtD
Phentolamine—Diarrhoea—Sorafenib—liver cancer	0.0103	0.0103	CcSEcCtD
Phentolamine—Dizziness—Sorafenib—liver cancer	0.00996	0.00998	CcSEcCtD
Phentolamine—Vomiting—Sorafenib—liver cancer	0.00957	0.0096	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—liver cancer	0.00957	0.00959	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—liver cancer	0.00957	0.00959	CcSEcCtD
Phentolamine—Angina pectoris—Epirubicin—liver cancer	0.00953	0.00956	CcSEcCtD
Phentolamine—Headache—Sorafenib—liver cancer	0.00943	0.00946	CcSEcCtD
Phentolamine—Nausea—Sorafenib—liver cancer	0.00894	0.00897	CcSEcCtD
Phentolamine—Angina pectoris—Doxorubicin—liver cancer	0.00882	0.00884	CcSEcCtD
Phentolamine—Bradycardia—Epirubicin—liver cancer	0.00797	0.00799	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—liver cancer	0.00738	0.0074	CcSEcCtD
Phentolamine—Cardiac disorder—Epirubicin—liver cancer	0.00727	0.00729	CcSEcCtD
Phentolamine—Flushing—Epirubicin—liver cancer	0.00727	0.00729	CcSEcCtD
Phentolamine—Angiopathy—Epirubicin—liver cancer	0.00711	0.00712	CcSEcCtD
Phentolamine—Mediastinal disorder—Epirubicin—liver cancer	0.00706	0.00708	CcSEcCtD
Phentolamine—Arrhythmia—Epirubicin—liver cancer	0.007	0.00701	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—liver cancer	0.00673	0.00674	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—liver cancer	0.00673	0.00674	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—liver cancer	0.00658	0.00659	CcSEcCtD
Phentolamine—Mediastinal disorder—Doxorubicin—liver cancer	0.00653	0.00655	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—liver cancer	0.00647	0.00649	CcSEcCtD
Phentolamine—Hypertension—Epirubicin—liver cancer	0.00589	0.0059	CcSEcCtD
Phentolamine—Chest pain—Epirubicin—liver cancer	0.0058	0.00582	CcSEcCtD
Phentolamine—Nervous system disorder—Epirubicin—liver cancer	0.00546	0.00547	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—liver cancer	0.00545	0.00546	CcSEcCtD
Phentolamine—Tachycardia—Epirubicin—liver cancer	0.00543	0.00544	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—liver cancer	0.00537	0.00538	CcSEcCtD
Phentolamine—Hypotension—Epirubicin—liver cancer	0.0052	0.00521	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—liver cancer	0.00505	0.00506	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—liver cancer	0.00503	0.00504	CcSEcCtD
Phentolamine—Paraesthesia—Epirubicin—liver cancer	0.005	0.00501	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—liver cancer	0.00481	0.00482	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Epirubicin—liver cancer	0.0048	0.00482	CcSEcCtD
Phentolamine—Pain—Epirubicin—liver cancer	0.00476	0.00477	CcSEcCtD
Phentolamine—Paraesthesia—Doxorubicin—liver cancer	0.00462	0.00463	CcSEcCtD
Phentolamine—Gastrointestinal pain—Epirubicin—liver cancer	0.00455	0.00456	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00445	0.00446	CcSEcCtD
Phentolamine—Pain—Doxorubicin—liver cancer	0.0044	0.00441	CcSEcCtD
Phentolamine—Abdominal pain—Epirubicin—liver cancer	0.0044	0.00441	CcSEcCtD
Phentolamine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00421	0.00422	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—liver cancer	0.00407	0.00408	CcSEcCtD
Phentolamine—Asthenia—Epirubicin—liver cancer	0.00399	0.004	CcSEcCtD
Phentolamine—Pruritus—Epirubicin—liver cancer	0.00394	0.00395	CcSEcCtD
Phentolamine—Diarrhoea—Epirubicin—liver cancer	0.00381	0.00382	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—liver cancer	0.00369	0.0037	CcSEcCtD
Phentolamine—Dizziness—Epirubicin—liver cancer	0.00368	0.00369	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—liver cancer	0.00364	0.00365	CcSEcCtD
Phentolamine—Vomiting—Epirubicin—liver cancer	0.00354	0.00355	CcSEcCtD
Phentolamine—Diarrhoea—Doxorubicin—liver cancer	0.00352	0.00353	CcSEcCtD
Phentolamine—Headache—Epirubicin—liver cancer	0.00349	0.00349	CcSEcCtD
Phentolamine—Dizziness—Doxorubicin—liver cancer	0.0034	0.00341	CcSEcCtD
Phentolamine—Nausea—Epirubicin—liver cancer	0.00331	0.00331	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—liver cancer	0.00327	0.00328	CcSEcCtD
Phentolamine—Headache—Doxorubicin—liver cancer	0.00323	0.00323	CcSEcCtD
Phentolamine—Nausea—Doxorubicin—liver cancer	0.00306	0.00307	CcSEcCtD
Phentolamine—ADRA1A—Signaling Pathways—H2AFX—liver cancer	9.06e-07	0.000376	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—IL2—liver cancer	9.06e-07	0.000376	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PPARA—liver cancer	8.96e-07	0.000372	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PIK3CB—liver cancer	8.96e-07	0.000372	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—ESR1—liver cancer	8.94e-07	0.000372	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—AKT1—liver cancer	8.89e-07	0.000369	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—PIK3CA—liver cancer	8.84e-07	0.000367	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—F2—liver cancer	8.83e-07	0.000367	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—BRAF—liver cancer	8.8e-07	0.000366	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—KDR—liver cancer	8.57e-07	0.000356	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TP53—liver cancer	8.55e-07	0.000355	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CSF2—liver cancer	8.54e-07	0.000355	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—RAF1—liver cancer	8.52e-07	0.000354	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK14—liver cancer	8.52e-07	0.000354	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—APC—liver cancer	8.45e-07	0.000351	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PIK3CG—liver cancer	8.45e-07	0.000351	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—KDR—liver cancer	8.44e-07	0.00035	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—H2AFX—liver cancer	8.42e-07	0.00035	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—IL2—liver cancer	8.41e-07	0.00035	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK14—liver cancer	8.38e-07	0.000348	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—ESR1—liver cancer	8.35e-07	0.000347	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PIK3CB—liver cancer	8.32e-07	0.000346	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PIK3CD—liver cancer	8.3e-07	0.000345	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—F2—liver cancer	8.25e-07	0.000343	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PIK3CD—liver cancer	8.23e-07	0.000342	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL2—liver cancer	8.22e-07	0.000342	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—ESR1—liver cancer	8.22e-07	0.000342	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ALB—liver cancer	8.2e-07	0.00034	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TERT—liver cancer	8.19e-07	0.00034	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—HRAS—liver cancer	8.18e-07	0.00034	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—PIK3CA—liver cancer	8.15e-07	0.000339	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SERPINE1—liver cancer	8.14e-07	0.000338	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—F2—liver cancer	8.12e-07	0.000337	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—KRAS—liver cancer	8.06e-07	0.000335	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—BRAF—liver cancer	7.95e-07	0.00033	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—APC—liver cancer	7.9e-07	0.000328	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PIK3CG—liver cancer	7.9e-07	0.000328	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PIK3CG—liver cancer	7.77e-07	0.000323	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—APC—liver cancer	7.77e-07	0.000323	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PIK3CG—liver cancer	7.67e-07	0.000319	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL2—liver cancer	7.64e-07	0.000317	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TERT—liver cancer	7.61e-07	0.000316	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KDR—liver cancer	7.49e-07	0.000311	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK14—liver cancer	7.45e-07	0.000309	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PIK3CD—liver cancer	7.43e-07	0.000309	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—BRAF—liver cancer	7.42e-07	0.000308	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—PIK3CA—liver cancer	7.4e-07	0.000308	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PPARG—liver cancer	7.4e-07	0.000308	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—PIK3CA—liver cancer	7.36e-07	0.000306	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SERPINE1—liver cancer	7.35e-07	0.000305	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RAF1—liver cancer	7.35e-07	0.000305	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—BRAF—liver cancer	7.31e-07	0.000303	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—ESR1—liver cancer	7.3e-07	0.000303	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—KRAS—liver cancer	7.28e-07	0.000302	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PIK3CB—liver cancer	7.24e-07	0.000301	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—AKT1—liver cancer	7.22e-07	0.0003	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—F2—liver cancer	7.21e-07	0.0003	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MTOR—liver cancer	7.18e-07	0.000298	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PIK3CB—liver cancer	7.18e-07	0.000298	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KDR—liver cancer	6.96e-07	0.000289	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PIK3CD—liver cancer	6.94e-07	0.000288	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK14—liver cancer	6.92e-07	0.000287	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PIK3CG—liver cancer	6.9e-07	0.000287	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APC—liver cancer	6.9e-07	0.000287	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—PIK3CA—liver cancer	6.88e-07	0.000286	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SERPINE1—liver cancer	6.87e-07	0.000285	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—HRAS—liver cancer	6.85e-07	0.000285	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PIK3CD—liver cancer	6.83e-07	0.000284	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—KRAS—liver cancer	6.8e-07	0.000282	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—ESR1—liver cancer	6.79e-07	0.000282	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—PIK3CA—liver cancer	6.77e-07	0.000281	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SERPINE1—liver cancer	6.76e-07	0.000281	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PIK3CD—liver cancer	6.74e-07	0.00028	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CDKN1B—liver cancer	6.73e-07	0.00028	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—F2—liver cancer	6.7e-07	0.000278	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—KRAS—liver cancer	6.69e-07	0.000278	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—PIK3CA—liver cancer	6.69e-07	0.000278	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—AKT1—liver cancer	6.66e-07	0.000277	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ALB—liver cancer	6.66e-07	0.000277	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RAF1—liver cancer	6.64e-07	0.000276	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CASP3—liver cancer	6.6e-07	0.000274	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL2—liver cancer	6.59e-07	0.000274	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—IL6—liver cancer	6.56e-07	0.000272	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—BRAF—liver cancer	6.49e-07	0.00027	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PIK3CB—liver cancer	6.48e-07	0.000269	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MTOR—liver cancer	6.48e-07	0.000269	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CCND1—liver cancer	6.42e-07	0.000267	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APC—liver cancer	6.41e-07	0.000266	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PIK3CG—liver cancer	6.41e-07	0.000266	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—JUN—liver cancer	6.41e-07	0.000266	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CTNNB1—liver cancer	6.36e-07	0.000264	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—PIK3CA—liver cancer	6.24e-07	0.000259	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MMP9—liver cancer	6.24e-07	0.000259	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CDKN1A—liver cancer	6.21e-07	0.000258	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RAF1—liver cancer	6.2e-07	0.000257	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—HRAS—liver cancer	6.19e-07	0.000257	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—PIK3CA—liver cancer	6.15e-07	0.000255	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RAF1—liver cancer	6.1e-07	0.000253	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CDKN1B—liver cancer	6.08e-07	0.000253	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PIK3CD—liver cancer	6.07e-07	0.000252	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MAPK8—liver cancer	6.07e-07	0.000252	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PIK3CB—liver cancer	6.05e-07	0.000251	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MTOR—liver cancer	6.05e-07	0.000251	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—AKT1—liver cancer	6.05e-07	0.000251	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—BRAF—liver cancer	6.03e-07	0.00025	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—AKT1—liver cancer	6.01e-07	0.00025	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—PIK3CA—liver cancer	6.01e-07	0.00025	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SERPINE1—liver cancer	6e-07	0.000249	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CASP3—liver cancer	5.96e-07	0.000248	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PIK3CB—liver cancer	5.96e-07	0.000247	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MTOR—liver cancer	5.96e-07	0.000247	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL2—liver cancer	5.95e-07	0.000247	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—KRAS—liver cancer	5.94e-07	0.000247	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—IL6—liver cancer	5.92e-07	0.000246	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PIK3CB—liver cancer	5.88e-07	0.000244	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CCND1—liver cancer	5.8e-07	0.000241	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—JUN—liver cancer	5.79e-07	0.00024	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—HRAS—liver cancer	5.78e-07	0.00024	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CTNNB1—liver cancer	5.74e-07	0.000239	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—HRAS—liver cancer	5.69e-07	0.000236	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CDKN1B—liver cancer	5.68e-07	0.000236	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	5.64e-07	0.000234	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MMP9—liver cancer	5.63e-07	0.000234	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—AKT1—liver cancer	5.62e-07	0.000233	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CDKN1A—liver cancer	5.61e-07	0.000233	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—VEGFA—liver cancer	5.6e-07	0.000233	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CDKN1B—liver cancer	5.59e-07	0.000232	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	5.59e-07	0.000232	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	5.58e-07	0.000232	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CASP3—liver cancer	5.57e-07	0.000231	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL2—liver cancer	5.56e-07	0.000231	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—STAT3—liver cancer	5.55e-07	0.00023	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—IL6—liver cancer	5.53e-07	0.00023	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—AKT1—liver cancer	5.53e-07	0.00023	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—KRAS—liver cancer	5.52e-07	0.000229	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CASP3—liver cancer	5.48e-07	0.000228	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MAPK8—liver cancer	5.48e-07	0.000227	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL2—liver cancer	5.47e-07	0.000227	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—AKT1—liver cancer	5.46e-07	0.000227	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—PIK3CA—liver cancer	5.46e-07	0.000227	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—IL6—liver cancer	5.44e-07	0.000226	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RAF1—liver cancer	5.42e-07	0.000225	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CCND1—liver cancer	5.42e-07	0.000225	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—JUN—liver cancer	5.41e-07	0.000225	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CTNNB1—liver cancer	5.36e-07	0.000223	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CCND1—liver cancer	5.33e-07	0.000221	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—JUN—liver cancer	5.32e-07	0.000221	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MTOR—liver cancer	5.29e-07	0.00022	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PIK3CB—liver cancer	5.29e-07	0.00022	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CTNNB1—liver cancer	5.28e-07	0.000219	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MMP9—liver cancer	5.26e-07	0.000218	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	5.24e-07	0.000218	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MMP9—liver cancer	5.18e-07	0.000215	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	5.16e-07	0.000214	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MYC—liver cancer	5.15e-07	0.000214	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TGFB1—liver cancer	5.14e-07	0.000214	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MAPK8—liver cancer	5.12e-07	0.000212	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—AKT1—liver cancer	5.1e-07	0.000212	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	5.07e-07	0.000211	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—VEGFA—liver cancer	5.06e-07	0.00021	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—HRAS—liver cancer	5.05e-07	0.00021	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MAPK8—liver cancer	5.03e-07	0.000209	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RAF1—liver cancer	5.03e-07	0.000209	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—AKT1—liver cancer	5.02e-07	0.000209	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—STAT3—liver cancer	5.01e-07	0.000208	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	4.96e-07	0.000206	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	4.92e-07	0.000204	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MTOR—liver cancer	4.92e-07	0.000204	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	4.91e-07	0.000204	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CASP3—liver cancer	4.87e-07	0.000202	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL2—liver cancer	4.86e-07	0.000202	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—IL6—liver cancer	4.83e-07	0.000201	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—KRAS—liver cancer	4.76e-07	0.000198	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CCND1—liver cancer	4.74e-07	0.000197	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—JUN—liver cancer	4.73e-07	0.000196	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—VEGFA—liver cancer	4.72e-07	0.000196	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—HRAS—liver cancer	4.69e-07	0.000195	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	4.69e-07	0.000195	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—STAT3—liver cancer	4.68e-07	0.000194	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MYC—liver cancer	4.65e-07	0.000193	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—VEGFA—liver cancer	4.65e-07	0.000193	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TGFB1—liver cancer	4.64e-07	0.000193	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	4.61e-07	0.000192	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—STAT3—liver cancer	4.6e-07	0.000191	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MMP9—liver cancer	4.6e-07	0.000191	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	4.58e-07	0.00019	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	4.56e-07	0.00019	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CASP3—liver cancer	4.52e-07	0.000188	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL2—liver cancer	4.51e-07	0.000188	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—IL6—liver cancer	4.49e-07	0.000187	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MAPK8—liver cancer	4.47e-07	0.000186	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—AKT1—liver cancer	4.46e-07	0.000185	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PIK3CA—liver cancer	4.41e-07	0.000183	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CCND1—liver cancer	4.4e-07	0.000183	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—JUN—liver cancer	4.39e-07	0.000182	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	4.37e-07	0.000182	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	4.36e-07	0.000181	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MYC—liver cancer	4.35e-07	0.000181	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TGFB1—liver cancer	4.33e-07	0.00018	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—KRAS—liver cancer	4.3e-07	0.000179	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MYC—liver cancer	4.28e-07	0.000178	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MMP9—liver cancer	4.27e-07	0.000177	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TGFB1—liver cancer	4.27e-07	0.000177	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	4.26e-07	0.000177	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TP53—liver cancer	4.23e-07	0.000176	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	4.15e-07	0.000173	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	4.14e-07	0.000172	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—VEGFA—liver cancer	4.13e-07	0.000172	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—STAT3—liver cancer	4.09e-07	0.00017	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HRAS—liver cancer	4.05e-07	0.000168	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—KRAS—liver cancer	4.02e-07	0.000167	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—KRAS—liver cancer	3.95e-07	0.000164	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	3.95e-07	0.000164	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—IL6—liver cancer	3.87e-07	0.000161	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	3.84e-07	0.000159	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TP53—liver cancer	3.82e-07	0.000159	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MYC—liver cancer	3.8e-07	0.000158	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—STAT3—liver cancer	3.8e-07	0.000158	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TGFB1—liver cancer	3.79e-07	0.000157	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	3.69e-07	0.000153	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HRAS—liver cancer	3.65e-07	0.000152	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	3.63e-07	0.000151	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—AKT1—liver cancer	3.6e-07	0.00015	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PIK3CA—liver cancer	3.58e-07	0.000149	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—AKT1—liver cancer	3.57e-07	0.000148	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TP53—liver cancer	3.57e-07	0.000148	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MYC—liver cancer	3.53e-07	0.000147	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	3.52e-07	0.000146	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TP53—liver cancer	3.51e-07	0.000146	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—KRAS—liver cancer	3.51e-07	0.000146	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—IL6—liver cancer	3.5e-07	0.000145	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HRAS—liver cancer	3.41e-07	0.000142	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HRAS—liver cancer	3.36e-07	0.00014	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—IL6—liver cancer	3.27e-07	0.000136	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—KRAS—liver cancer	3.26e-07	0.000135	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—AKT1—liver cancer	3.23e-07	0.000134	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	3.22e-07	0.000134	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—IL6—liver cancer	3.21e-07	0.000134	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TP53—liver cancer	3.12e-07	0.00013	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—AKT1—liver cancer	3.01e-07	0.000125	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	3e-07	0.000124	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HRAS—liver cancer	2.98e-07	0.000124	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—AKT1—liver cancer	2.97e-07	0.000123	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—AKT1—liver cancer	2.93e-07	0.000122	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TP53—liver cancer	2.9e-07	0.00012	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—IL6—liver cancer	2.86e-07	0.000119	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HRAS—liver cancer	2.77e-07	0.000115	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—IL6—liver cancer	2.65e-07	0.00011	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—AKT1—liver cancer	2.63e-07	0.000109	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—AKT1—liver cancer	2.45e-07	0.000102	CbGpPWpGaD
